Institutional Product Sheet
Abscort 6
Targeted Corticosteroid Therapy for
Inflammatory & Autoimmune Management
Product Overview
Abscort 6 is a brand of deflazacort, a corticosteroid medication primarily
used to treat Duchenne muscular dystrophy (DMD) by reducing muscle
inflammation and damage. It also helps manage various inflammatory and
autoimmune conditions like arthritis, severe allergies, asthma, and flare-ups
of chronic illnesses.
Clinical Applications
Respiratory Management
Effective in controlling severe
asthma flare-ups and chronic
respiratory inflammatory
conditions.
Autoimmune Support
Used in management of arthritis
and diverse autoimmune disorders
to suppress pathological immune
responses.
Severe Allergies
Rapid response for acute allergic
reactions that require systemic
corticosteroid intervention.
Usage & Administration
Oral Intake
Take Abscort 6 orally with or without food. Consistency is key for optimal therapeutic levels—ideally at the same time each day.
Prescription Adherence
Your healthcare provider will specify the exact dose based on age, weight, and the specific medical condition being treated.
Handling Instructions
Swallow the tablet whole; do not crush or chew. This ensures the intended release profile of the medication is maintained.
Critical Safety Note
Avoid abruptly stopping the medication to prevent withdrawal symptoms. Dosage must always be tapered under strict medical guidance.
Clinical Cautions
ABSORPTION WARNING
Avoid antacids 2 hours before/after
to ensure optimal absorption.
MEDICAL DISCLOSURE
Tell your doctor if you are pregnant,
breastfeeding, or on other
medications.
SIDE
EFFECTS
Report severe diarrhea, vomiting, or
constipation to your clinician.